Investment Rating - Industry Rating: Outperform the Market (maintained rating) [1] Core Viewpoints - The report highlights the ongoing challenges in the poultry industry due to the rising incidence of highly pathogenic avian influenza (HPAI), particularly in Europe, which has seen a significant increase in reported cases [4][5] - The report suggests that the heightened risk level for avian influenza in France may indicate an earlier onset of the flu season, impacting poultry farming practices and potentially leading to increased biosecurity measures [5] - There is a notable decline in the domestic breeding stock imports, with a 29.1% year-on-year decrease in the first nine months of 2025, primarily due to the suspension of imports from the US and New Zealand [6] Summary by Sections Industry Overview - The poultry industry is currently facing a critical period with the global outbreak of HPAI, which has resulted in 1,374 new cases reported globally, marking a 61.5% increase year-on-year [4] - The report emphasizes the need for close monitoring of overseas breeding stock imports and the structural changes in breeding practices as a response to the avian influenza threat [6] Market Trends - The report indicates that the poultry market is experiencing fluctuations, with a focus on the implications of avian influenza on supply chains and pricing strategies [6] - The report recommends paying attention to the emergence of domestic breeding opportunities and the importance of securing alternative breeding resources [6] Investment Recommendations - The report recommends focusing on companies that are well-positioned to adapt to the changing landscape, specifically highlighting Shengnong Development as a key player, while also suggesting to monitor Yisheng Livestock, Minhe Livestock, Hefeng Livestock, and Xiantan Livestock for potential investment opportunities [6]
全球进入禽流感高发季,建议关注白鸡海外引种情况